
Keywords: مهار کننده بازجذب سروتونین انتخابی; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AUD; alcohol use disorder; FDA; Food and Drug Administration; GABAAR; γ-aminobutyric acid receptor; NAc; nucleus accumbens; nAChRs; nicotinic acetylcholine receptors; NMDA; N-methyl-d-aspartate